The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease
Open accessAbstract
Deficiency in docosahexaenoic acid (DHA), a brain-essential omega-3 fatty acid, is associated with cognitive decline. Here we report that, in cytokine-stressed human neural cells, DHA attenuates amyloid-beta (Abeta) secretion, an effect accompanied by the formation of NPD1, a novel, DHA-derived 10,17S-docosatriene. DHA and NPD1 were reduced in Alzheimer disease (AD) hippocampal cornu ammonis region 1, but not in the thalamus or occipital lobes from the same brains. The expression of key enzymes in NPD1 biosynthesis, cytosolic phospholipase A2 and 15-lipoxygenase, was altered in AD hippocampus. NPD1 repressed Abeta42-triggered activation of proinflammatory genes while upregulating the antiapoptotic genes encoding Bcl-2, Bcl-xl, and Bfl-1(A1). Soluble amyloid precursor protein-alpha stimulated NPD1 biosynthesis from DHA. These results indicate that NPD1 promotes brain cell survival via the induction of antiapoptotic and neuroprotective gene-expression programs that suppress Abeta42-induced neurotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000 · cited 3×
“PDA-ESI-MS-MS according to reported biophysical criteria (6, 49).”
BackgroundMethodInfluentialDietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Self-citationMukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753 · cited 10×
“The unesterified DHA pool size assessed by liquid chromatography–photodiode array–electrospray ionization–tandem mass spectrometry–based (LC-PDA-ESI-MS-MS–based) lipidomic analysis (5, 6) (Figure 1I) showed that neither Aβ42 nor sAPPα was able to promote unesterFigure 2 Aβ42-induced apoptosis is inhibited by NPD1 in H…”
InfluentialDocosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model
Calon, F., Lim, G. P., Yang, F., Morihara, T., Teter, B., Ubeda, O., Rostaing, P., Triller, A., Salem, N., Ashe, K. H., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.013 · Cited by 707
Lim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4225-04.2005 · Cited by 686
Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667
N OTCH AND P RESENILIN: Regulated Intramembrane Proteolysis Links Development and Degeneration
Selkoe, D., & Kopan, R. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131334 · Cited by 636
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517 · cited 10×
“marker for inflammatory and oxidative stress responses (4, 33), and”
BackgroundInfluentialSelf-citationFish, meat, and risk of dementia: cohort study
Barberger-Gateau, P. (2002) · BMJ · doi:10.1136/bmj.325.7370.932 · Cited by 486
Inflammatory processes in Alzheimer's disease
McGeer, E. G., & McGeer, P. L. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00124-6 · Cited by 472
Montine, T. J., Neely, M. D., Quinn, J. F., Beal, M. F., Markesbery, W. R., Roberts, L. J., & Morrow, J. D. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00807-9 · Cited by 449
Membrane docosahexaenoate is supplied to the developing brain and retina by the liver.
Scott, B. L., & Bazan, N. G. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2903 · Cited by 440
Regional Membrane Phospholipid Alterations in Alzheimer's Disease
Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 439
Zhang, Y., McLaughlin, R., Goodyer, C., & LeBlanc, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110119 · Cited by 418
Liao, Y.-F., Wang, B.-J., Cheng, H.-T., Kuo, L.-H., & Wolfe, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402034200 · Cited by 389 · cited 4×
“IL-1β directly stimulates γ-secretase–mediated cleavage of βAPP into Aβ peptides through a JNK-dependent MAPK pathway (34).”
InfluentialBazan, N. G. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00513.x · Cited by 365
Hashimoto, M., Tanabe, Y., Fujii, Y., Kikuta, T., Shibata, H., & Shido, O. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.3.549 · Cited by 288
Bazan, N. G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300013-jlr200 · Cited by 247
Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes
Xu, J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., & Hsu, C. Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0001.2001 · Cited by 230
Selective neuronal degeneration induced by soluble oligomeric amyloid beta‐protein
Kim, H., Chae, S., Lee, D., Chromy, B., Cheol Lee, S., Park, Y., Klein, W. L., Krafft, G. A., & Hong, S. (2003) · The FASEB Journal · doi:10.1096/fj.01-0987fje · Cited by 210
Bcl-2 family regulation of neuronal development and neurodegeneration
Akhtar, R. S., Ness, J. M., & Roth, K. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.013 · Cited by 210
The significance of environmental factors in the etiology of Alzheimer's disease
Grant, W. B., Campbell, A., Itzhaki, R. F., & Savory, J. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4308 · Cited by 208
Gamoh, S., Hashimoto, M., Hossain, S., & Masumura, S. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03437.x · Cited by 205
Guo, Q., Robinson, N., & Mattson, M. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12341 · Cited by 196
Suzuki, H., Park, S. J., Tamura, M., & Ando, S. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(97)00169-3 · Cited by 194
Cognitive deficits in docosahexaenoic acid-deficient rats.
Catalan, J., Toru, M., Slotnick, B., Murthy, M., Greiner, R. S., & Salem, N., Jr. (2002) · Behavioral Neuroscience · doi:10.1037//0735-7044.116.6.1022 · Cited by 190
F4 ‐ Isoprostanes as Specific Marker of Docosahexaenoic Acid Peroxidation in Alzheimer's Disease
Nourooz‐Zadeh, J., Liu, E. H. C., Yhlen, B., Änggåard, E. E., & Halliwell, B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720734.x · Cited by 187
Turner, R. S., Suzuki, N., Chyung, A. S. C., Younkin, S. G., & Lee, V. M.-Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8966 · Cited by 161
Ikemoto, A., Ohishi, M., Sato, Y., Hata, N., Misawa, Y., Fujii, Y. R., & Okuyama, H. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32220-3 · Cited by 150
Low serum docosahexaenoic acid is a significant risk factor for alzheimer's dementia
Kyle, D. J., Schaefer, E. J., Patton, G. M., & Beiser, A. (1999) · Lipids · doi:10.1007/bf02562306 · Cited by 140
Bahr, B. A., Hoffman, K. B., Yang, A. J., Hess, U. S., Glabe, C. G., & LYNCH, G. S. (1998) · PubMed · Cited by 116
Metcalfe, A. D., Hunter, H. R., Bloor, D. J., Lieberman, B. A., Picton, H. M., Leese, H. J., Kimber, S. J., & Brison, D. R. (2004) · Molecular Reproduction and Development · doi:10.1002/mrd.20055 · Cited by 104
Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203201200 · Cited by 101
Self-citationAlzheimer Degeneration in Down Syndrome: Electrophysiologic Alterations and Histopathologic Findings
Crapper, D. R. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510074006 · Cited by 93
Cheng, G., Yu, Z., Zhou, D., & Mattson, M. P. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7920 · Cited by 88
Lahiri, D. K., Chen, D., Vivien, D., Ge, Y.-W., Greig, N. H., & Rogers, J. T. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5203 · Cited by 81 · cited 1×
“These noxious stimuli further orchestrate pathogenic gene-expression programs in stressed brain cells, thereby linking a cascade of caspase-mediated cell death pathways with apoptosis and neuronal demise (3, 33, 48).”
BackgroundInterferon γ stimulates β-secretase expression and sAPPβ production in astrocytes
Hong, H. S., Hwang, E. M., Sim, H. J., Cho, H.-J., Boo, J. H., Oh, S. S., Kim, S. U., & Mook-Jung, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01270-1 · Cited by 81 · cited 1×
“Amyloid peptide–mediated oxidative stress, the activation of microglia associated with Aβ peptide deposition, and excessive production of microglial-derived cytokines such as IL-1β and TNF-α support progressive inflammatory episodes in AD (4, 32, 38, 47).”
BackgroundNeocortical Glial Cell Numbers in Alzheimer’s Disease
Pelvig, D. P., Pakkenberg, H., Regeur, L., Oster, S., & Pakkenberg, B. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000072805 · Cited by 81 · cited 1×
“Quantitative morphometric analysis of AD brains shows a dropout of neurons; depending on brain region and stage of disease development, the population of neurons remaining in AD brain has been estimated to range from 59% (39), to 77% (40), to 89% (41) of age-matched controls for the same brain region.”
BackgroundPrevalence of dementia in the older Japanese‐Brazilian population
Yamada, T., 嘉手苅初子, Matsumoto, S., Inada, H., Tanabe, M., Moriguchi, E. H., Moriguchi, Y., Ishikawa, P., Ishikawa, A. G., Taira, K., et al. (2002) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2002.00931.x · Cited by 76
Astrocyte modulation of in vitro β‐amyloid neurotoxicity
Paradisi, S., Sacchetti, B., Balduzzi, M., Gaudi, S., & Malchiodi‐Albedi, F. (2004) · Glia · doi:10.1002/glia.20005 · Cited by 68
Kobayashi, K., Hayashi, M., Nakano, H., Shimazaki, M., Sugimori, K., & Koshino, Y. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6606 · Cited by 58
Webster, N. J., Green, K. N., Peers, C., & Vaughan, P. F. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01236.x · Cited by 56 · cited 1×
“It is interesting that muscarine, a positive regulator of PLA2, is also a potent inducer of sAPPα in human neuroblastoma SH-SY5Y cells (30, 31); therefore, the enzymatic pathways involving PLA2-mediated DHA and NPD1 biosynthesis may exhibit positive feedback regulation through sAPPα.”
BackgroundApoptotic cell death in neurons and glial cells: implications for Alzheimer's disease
Yoshihisa, K., Takashi, T., & Shun, S. (1999) · Japanese Journal of Pharmacology · doi:10.1254/jjp.79.1 · Cited by 47
Kaur, J., Dhaunsi, G. S., & Turner, R. B. (2003) · Medical Principles and Practice · doi:10.1159/000074047 · Cited by 41
Tarte, K., Jourdan, M., Veyrune, J. L., Berberich, I., Fiol, G., Redal, N., Shaughnessy, J., & Klein, B. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04908.x · Cited by 28
Stein, T. D., & Johnson, J. A. (2003) · Reviews in the Neurosciences · doi:10.1515/revneuro.2003.14.4.317 · Cited by 27
Wood, M. W., Segal, J. A., Mark, R. J., Ogden, A. M., & Felder, C. C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742033.x · Cited by 11
Cited by
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3820 · Cited by 1,605
Emerging targets in neuroinflammation-driven chronic pain
Ji, R.-R., Xu, Z.-Z., & Gao, Y.-J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4334 · Cited by 1,101
Metadata
- Authors
- Lukiw, W. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-10-01
- Volume
- 115
- Issue
- 10
- Pages
- 2774-2783
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2157340973
- Cited by
- 872
- References
- 49
- FWCI
- 40.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.